Management approaches for ADHD during the COVID-19 virus pandemic: guidance from the European ADHD Guidelines Group (EAGG)

The current COVID-19 virus crisis is creating unprecedented challenges at every level of society. Individuals with neurodevelopmental disorders such as Attention-Deficit/Hyperactivity Disorder (ADHD) are particularly vulnerable and may display increased behavioural problems. The current crisis also poses several important questions for their clinicians on how best to deliver care within the new restrictions. This document provides a summary of the guidance on the assessment and management of ADHD during the COVID-19 virus pandemic, developed by the European ADHD Guidelines Group (EAGG). The full guidance is reported in the Appendix.